Janssen

DARZALEX

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / DARZALEX – J9145

Manufacturer:

Janssen

Name:

DARZALEX

HCPCS Code Descriptor:

Injection, daratumumab, 10 mg

Category:

J Code

HCPCS:

J9145

NDC(s):

57894-0502-20, 57894-0502-05

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

DARZALEX is an Oncology drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9145 is aligned to the drug DARZALEX.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/17

HCPCS Effective Date:

1/1/17

HCPCS Short Description:

Injection, daratumumab 10 mg

Billing and Coding Guide:

https://www.janssencarepath.com/hcp/sites/www.janssencarepath-v2.com.hcp/files/darzalex-faspro-reimbursement-and-access-guide.pdf?v=128

Patient Assistance:

http://www.jjpaf.org/

DARZALEX - J9145